These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 12042579

  • 1. Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.
    Romagnoli C, Zecca E, Luciano R, Torrioli G, Tortorolo G.
    Pediatrics; 2002 Jun; 109(6):e85. PubMed ID: 12042579
    [Abstract] [Full Text] [Related]

  • 2. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA, Doyle LW.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD001145. PubMed ID: 19160189
    [Abstract] [Full Text] [Related]

  • 3. A three year follow up of preterm infants after moderately early treatment with dexamethasone.
    Romagnoli C, Zecca E, Luciano R, Torrioli G, Tortorolo G.
    Arch Dis Child Fetal Neonatal Ed; 2002 Jul 21; 87(1):F55-8. PubMed ID: 12091294
    [Abstract] [Full Text] [Related]

  • 4. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA, Doyle LW.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD001146. PubMed ID: 19160190
    [Abstract] [Full Text] [Related]

  • 5. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA, Doyle LW.
    Cochrane Database Syst Rev; 2003 Jan 21; (1):CD001146. PubMed ID: 12535402
    [Abstract] [Full Text] [Related]

  • 6. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Doyle LW, Ehrenkranz RA, Halliday HL.
    Cochrane Database Syst Rev; 2014 May 13; (5):CD001146. PubMed ID: 24825456
    [Abstract] [Full Text] [Related]

  • 7. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA, Doyle LW.
    Cochrane Database Syst Rev; 2003 May 13; (1):CD001145. PubMed ID: 12535401
    [Abstract] [Full Text] [Related]

  • 8. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Doyle LW, Ehrenkranz RA, Halliday HL.
    Cochrane Database Syst Rev; 2014 May 13; (5):CD001145. PubMed ID: 24825542
    [Abstract] [Full Text] [Related]

  • 9. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA.
    Cochrane Database Syst Rev; 2001 May 13; (2):CD001145. PubMed ID: 11405975
    [Abstract] [Full Text] [Related]

  • 10. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA.
    Cochrane Database Syst Rev; 2000 May 13; (2):CD001146. PubMed ID: 10796252
    [Abstract] [Full Text] [Related]

  • 11. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA.
    Cochrane Database Syst Rev; 2001 May 13; (1):CD001146. PubMed ID: 11279706
    [Abstract] [Full Text] [Related]

  • 12. Early postnatal dexamethasone therapy for the prevention of chronic lung disease.
    Vermont Oxford Network Steroid Study Group.
    Pediatrics; 2001 Sep 13; 108(3):741-8. PubMed ID: 11533345
    [Abstract] [Full Text] [Related]

  • 13. Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants.
    Romagnoli C, Zecca E, Vento G, De Carolis MP, Papacci P, Tortorolo G.
    Intensive Care Med; 1999 Jul 13; 25(7):717-21. PubMed ID: 10470576
    [Abstract] [Full Text] [Related]

  • 14. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA.
    Cochrane Database Syst Rev; 2000 Jul 13; (2):CD001144. PubMed ID: 10796416
    [Abstract] [Full Text] [Related]

  • 15. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS, Ohlsson A, Halliday H, Shah VS.
    Cochrane Database Syst Rev; 2003 Jul 13; (2):CD002057. PubMed ID: 12804423
    [Abstract] [Full Text] [Related]

  • 16. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy.
    Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, Arbel E, Goldberg M, Gur I, Naor N, Sirota L, Mogilner S, Zaritsky A, Barak M, Gottfried E.
    Arch Dis Child Fetal Neonatal Ed; 2000 Nov 13; 83(3):F177-81. PubMed ID: 11040164
    [Abstract] [Full Text] [Related]

  • 17. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA.
    Cochrane Database Syst Rev; 2001 Nov 13; (1):CD001144. PubMed ID: 11279705
    [Abstract] [Full Text] [Related]

  • 18. Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial.
    Romagnoli C, Zecca E, Vento G, Maggio L, Papacci P, Tortorolo G.
    Pharmacology; 1999 Nov 13; 59(5):266-74. PubMed ID: 10529659
    [Abstract] [Full Text] [Related]

  • 19. Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy.
    Lin YJ, Yeh TF, Hsieh WS, Chi YC, Lin HC, Lin CH.
    Pediatr Pulmonol; 1999 Jan 13; 27(1):21-6. PubMed ID: 10023787
    [Abstract] [Full Text] [Related]

  • 20. Update on Postnatal Steroids.
    Halliday HL.
    Neonatology; 2017 Jan 13; 111(4):415-422. PubMed ID: 28538237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.